Metabolomics for predicting fetal growth restriction: protocol for a systematic review and meta-analysis



Batista Leite, Debora Farias, Morillon, Aude-Claire, Melo Junior, Elias F, Souza, Renato T, Khashan, Ali S, Baker, Philip N, Kenny, Louise C ORCID: 0000-0002-9011-759X and Cecatti, Jose Guilherme
(2018) Metabolomics for predicting fetal growth restriction: protocol for a systematic review and meta-analysis. BMJ OPEN, 8 (12). e022743-.

Access the full-text of this item by clicking on the Open Access link.

Abstract

<h4>Introduction</h4>Fetal growth restriction (FGR) is a relevant research and clinical concern since it is related to higher risks of adverse outcomes at any period of life. Current predictive tools in pregnancy (clinical factors, ultrasound scan, placenta-related biomarkers) fail to identify the true growth-restricted fetus. However, technologies based on metabolomics have generated interesting findings and seem promising. In this systematic review, we will address diagnostic accuracy of metabolomics analyses in predicting FGR.<h4>Methods and analysis</h4>Our primary outcome is small for gestational age infant, as a surrogate for FGR, defined as birth weight below the 10th centile by customised or population-based curves for gestational age. A detailed systematic literature search will be carried in electronic databases and conference abstracts, using the keywords 'fetal growth retardation', 'metabolomics', 'pregnancy' and 'screening' (and their variations). We will include original peer-reviewed articles published from 1998 to 2018, involving pregnancies of fetuses without congenital malformations; sample collection must have been performed before clinical recognition of growth impairment. If additional information is required, authors will be contacted. Reviews, case reports, cross-sectional studies, non-human research and commentaries papers will be excluded. Sample characteristics and the diagnostic accuracy data will be retrieved and analysed. If data allows, we will perform a meta-analysis.<h4>Ethics and dissemination</h4>As this is a systematic review, no ethical approval is necessary. This protocol will be publicised in our institutional websites and results will be submitted for publication in a peer-reviewed journal.<h4>Prospero registration number</h4>CRD42018089985.

Item Type: Article
Uncontrolled Keywords: Humans, Fetal Growth Retardation, Risk Factors, Cross-Sectional Studies, Predictive Value of Tests, Pregnancy, Infant, Newborn, Infant, Small for Gestational Age, Female, Meta-Analysis as Topic, Metabolomics, Systematic Reviews as Topic
Depositing User: Symplectic Admin
Date Deposited: 16 Jan 2019 14:58
Last Modified: 23 Aug 2023 16:53
DOI: 10.1136/bmjopen-2018-022743
Open Access URL: https://bmjopen.bmj.com/content/8/12/e022743
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3031380